Hite Christopher Insider Trades & Stock Holdings

EVP & Chairman, Partnering · Royalty Pharma plc · Latest filing Sep 22, 2026

Hite Christopher, EVP & Chairman, Partnering at Royalty Pharma plc has 1 Form 4 trade on file since Sep 22, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($5.85M), net -$5.85M. Latest filing: disposed of 100K shares of $RPRX on Sep 22, 2026 at $58.53.

Trades on file

1

Open-market bought

$0

Open-market sold

$5.85M

Net open-market

-$5.85M

Latest filing

Sep 22, 2026

All insider trades by Hite Christopher

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 22, 2026	$RPRX	Sell (Open-market sale) 10b5-1	100K	$58.53	$5.85M			-0.5%			EVP & Chairman, Partnering		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Hite Christopher traded

• $RPRX

Frequently asked questions

Has Hite Christopher been buying or selling stock?

Hite Christopher has 0 open-market purchases and 1 open-market sale on file, net -$5.85M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Hite Christopher's latest insider trade?

disposed of 100K shares of $RPRX on Sep 22, 2026 at $58.53.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.